58 results
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
14 May 24
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
4:17pm
Ended
Three Months
Ended
March 31,
Operating Expenses
Research and development
Sales and marketing
General and administrative
Total operating expenses … in the first quarter of 2024 were $2.8 million, compared with $2.9 million in the first quarter in 2023. The decrease was mainly due to lower research
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
28 Mar 24
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
was mainly due to lower research and development and general and administrative expenses.
Net loss in the fourth quarter of 2023 was $1.5 million …
Operating expenses in 2023 were $10.5 million, compared with $13.2 million in 2022. The decrease was mainly due to lower research and development and sales
8-K
EX-99.1
20y09d xxm2uqvdxb
14 Nov 23
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
4:02pm
8-K
EX-99.1
or68ogvu0hgr48d1i
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.1
to7s9xiemcsey5bl
15 May 23
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
12:00am
8-K
EX-99.1
9clyr9z1iut1t9a55k
14 Nov 22
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4:32pm
8-K
EX-99.1
rl2uh2y9af
15 Aug 22
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
5:17pm
8-K
EX-99.1
43kvkt4g1 ujf
12 May 22
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
4:06pm